Category: AngioDynamics Inc.Syndicate content

AngioDynamics taps Concert Medical president Donnelly as chairman

April 29, 2014 by Brad Perriello

AngioDynamics names Concert Medical president Howard Donnelly as chairman, replacing Vincent Bucci, who stepped down last month.

AngioDynamics taps Concert Medical president Donnelly as chairman

AngioDynamics (NSDQ:ANGO) said today that it tapped Concert Medical president Howard Donnelly to replace outgoing chairman Vincent Bucci.

Bucci, 1st named to the AngioDynamics board in 2007, was named chairman later that year. He stepped down in March.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

AngioDynamics swings to Q3 black, beats The Street

April 14, 2014 by Brad Perriello

AngioDynamics reports a profitable fiscal 3rd quarter and nearly doubles Wall Street's earnings forecast, but shares slide anyway.

AngioDynamics swings to Q3 black, beats The Street

AngioDynamics (NSDQ:ANGO) put some black ink in the ledger during its fiscal 3rd quarter and handily topped Wall Street's earnings forecast, but investors have remained unmoved, sending ANGO shares down 12% since its April 9 earnings release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolitec slapped with $75M judgment in AngioDynamics suit

March 20, 2014 by Brad Perriello

AngioDynamics wins a nearly $75 million judgment against erstwhile partner Biolitec AG over an alleged scheme to evade U.S legal jurisdiction.

Biolitec slapped with $75M judgment in AnioDynamics suit

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

AngioDynamics lands expanded FDA clearance for AngioVac drainage system

March 11, 2014 by Arezu Sarvestani

New York's AngioDynamics wins updated labeling from FDA regulators, indicating its AngioVac venous drainage system for up to 6 hours at a time.

AngioDynamics lands expanded FDA clearance for AngioVac drainage system

AngioDynamics (NSDQ:ANGO) tallied a new win for its AngioVac drainage system, with new FDA clearance to market the device for extended use.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

AngioDynamics lands FDA win, takes over 510(k) process for rejected Medcomp

March 7, 2014 by Arezu Sarvestani

New York's AngioDynamics lands FDA clearance for a new BioFlo product and takes charge of distribution partner Medcomp's Celerity tip locater after an FDA loss.

AngioDynamnics lands FDA win, takes over 510(k) process for Medcomp

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolitec appeals CEO arrest warrant, $63M sanction in AngioDynamics case

February 12, 2014 by Brad Perriello

Biolitec AG appeals a Massachusetts federal judge's issuance of an arrest warrant for its CEO and a $63 million sanction in its legal war with AngioDynamics.

Biolitec appeals CEO arrest warrant, $63M sanction in AngioDynamics case

AngioDynamics settles discrimination lawsuit with ex-employee

January 13, 2014 by Arezu Sarvestani

New York's AngioDynamics closes the books on an employee discrimination lawsuit with neither party admitting wrongdoing.

AngioDynamics settles discrimination lawsuit with former employee

Medtech maker AngioDynamics (NSDQ:ANGO) finally put to bed a former employee's discrimination lawsuit, ending the quarrel with neither party admitting to any wrongdoing.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp